Meeting, the world's largest conference dedicated to longevity biotechnology, will take place from October 1-3, 2026, at the David Rubenstein Treehouse at Harvard University.
A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.
Simplilearn, a global leader in digital upskilling, in collaboration with UC Santa Barbara Professional and Continuing Education (UCSB PaCE), has launched the Professional Certificate in AI and ...
The University of Hohenheim becomes a European University through the EuroLeague of Life Sciences Universities (ELLS). The ...
Michelle Sisto, director of the EDHEC AI Centre, opens a London panel on AI and the future of work with a keynote on how AI ...
Cal Lutheran University’s Fifty and Better program will conclude its 2026 FABulous Summer Lecture Series and summer activities in August with a selection of university-level lectures covering history, ...
Boston, MA – July 8, 2026 – The award-winning PBS science series, NOVA, part of the GBH documentary unit, today announced EVOLUTION, a new five-part series that traces the epic journey of life, from a ...
This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...
Cyprus Mail on MSN
No biological law says we must age: Sinclair debuts Evolve Lecture Series at UNIC Athens
UNIC Athens has launched its new Evolve Lecture Series with an inaugural lecture by David Sinclair, Professor of Genetics at Harvard Medical School and one of the world’s foremost researchers on ...
Researchers at Hospital for Special Surgery (HSS) have uncovered a critical link between the immune system in early life and ...
Editor’s note: This article appeared in the Armenian Weekly’s March 2026 special magazine issue, “America at 250: An Armenian American Retrospective,” guest edited by former Weekly editor Dr. Khatchig ...
The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first target, it could have applications for a variety of age-related disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results